Received Apr 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Severe rash on neck and chest; itchy; This non-serious case was reported by a consumer and described the occurrence of rash in a 50-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Concurrent medical conditions included menopause and progesterone. Concomitant products included estradiol and trazodone. On 14-APR-2025, the patient received Shingles vaccine. On 15-APR-2025, 1 days after receiving Shingles vaccine, the patient experienced rash (Verbatim: Severe rash on neck and chest). In APR-2025, the patient experienced pruritus (Verbatim: itchy). The patient was treated with acrivastine (Benadryl). The outcome of the rash was not resolved and the outcome of the pruritus was not reported. It was unknown if the reporter considered the rash and pruritus to be related to Shingles vaccine. It was unknown if the company considered the rash and pruritus to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 15-APR-2025 The rash was mildly itchy and feels like a sunburn (Severe rash on neck and chest) The symptoms were treated.
Menopause; Progesterone
Trazodone; estradiol